Friday 03 September 2010
While the State has earmarked nearly €750 million for Cancer Plan II by 2013, including 15% for studying the related environmental and behavioural risks, CEA is investing in two main areas: molecular imaging and cancer genetics. Keys for improved diagnoses and new treatments. Read the file
| 
|
Type of actions
Assessment and consultancy, providing testing and simulation resources, technology transfers, license and patent agreements, research partnerships, joint laboratories, etc.
subject areas
Micro and nanotechnologies, Energy and New energy technologies, Life sciences, health & biotechnology , Materials and nanomaterials, Software Technologies, Process-Instrumentation-Measurements.
